MedTrace Logo

Assessment of a Proposed Microbiological Alert and Its Impact on a Sepsis Campaign

NCT02325258 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 300

Last updated 2014-12-30

No results posted yet for this study

Summary

The aim of the present study was to evaluate the ability of health-care professionals in addressing sepsis, and the impact of a telephone call upon receival of blood cultures in the clinical microbiology department, from a clinical microbiologist, in the early management of sepsis.

Conditions

Interventions

OTHER

Telephone call

Aug-Dec 2012. Prospective study in patients who had blood cultures drawn and sent to the Microbiology Lab during the morning shift (9 am to 3 pm, Mon- Fri) to evaluate sepsis recognition. The investigators allocated 300 patients to 2 groups of 150 patients each, by opportunity sampling: patients whose clinical history number ended in odd numbers were assigned to group A (intervention) and those whose clinical history number ended in even numbers were assigned to group B (no intervention, control group). For patients in group A, the investigators attempted a telephone contact with the physician and/or nurse in charge and an interview, issuing recommendations regarding the convenience of further biochemical, microbiological or extra radiologic tests, and management and antimicrobial therapy.

Sponsors & Collaborators

  • Emilio Bouza

    lead OTHER

Principal Investigators

  • Emilio Bouza Santiago, MD, PhD · Servicio de Microbiología y Enfermedades Infecciosas

  • Eleonora Bunsow, MD, PhD · Servicio de Microbiología y Enfermedades Infecciosas

  • Marcela González Del Vecchio, MD · Servicio de Microbiología y Enfermedades Infecciosas

  • Carlos Sánchez, PharmD · Servicio de Microbiología y Enfermedades Infecciosas

  • Patricia Muñoz García, MD, PhD · Servicio de Microbiología y Enfermedades Infecciosas

  • Almudena Burillo, MD, PhD · Servicio de Microbiología y Enfermedades Infecciosas

Study Design

Allocation
NON_RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-08-31
Primary Completion
2013-01-31
Completion
2013-01-31

Countries

  • Spain

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02325258 on ClinicalTrials.gov